FULC

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Fulcrum Therapeutics Inc

NASDAQ | FULC

7.32

USD

+$0.00

(

+0.00%

)

At Close (As of Sep 17, 2025)

$394.87M

Market Cap

-

P/E Ratio

-1.18

EPS

$8.50

52 Week High

$2.31

52 Week Low

HEALTHCARE

Sector

FULC Chart

Recent Chart
Price Action

FULC Technicals

Tags:

FULC Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $78M
Total Revenue $80M
Cost Of Revenue $1.6M
Costof Goods And Services Sold $1.6M
Operating Income -$22M
Selling General And Administrative $36M
Research And Development $63M
Operating Expenses $102M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.6M
Income Before Tax -$9.7M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$9.7M
Comprehensive Income Net Of Tax -
Ebit -$20M
Ebitda -$18M
Net Income -$9.7M

Revenue & Profitability

Earnings Performance

FULC Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $261M
Total Current Assets $250M
Cash And Cash Equivalents At Carrying Value $58M
Cash And Short Term Investments $58M
Inventory -
Current Net Receivables $3.3M
Total Non Current Assets $11M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $183M
Other Current Assets $5.6M
Other Non Current Assets -
Total Liabilities $18M
Total Current Liabilities $11M
Current Accounts Payable $1.2M
Deferred Revenue -
Current Debt -
Short Term Debt $2.2M
Total Non Current Liabilities $6.6M
Capital Lease Obligations $8.6M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $8.6M
Other Current Liabilities $7.7M
Other Non Current Liabilities $197K
Total Shareholder Equity $243M
Treasury Stock -
Retained Earnings -$519M
Common Stock $54K
Common Stock Shares Outstanding $62M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$2.2M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $1.6M
Capital Expenditures $278K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $32M
Cashflow From Financing $2.7M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$9.7M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $78M
Total Revenue $80M
Cost Of Revenue $1.6M
Costof Goods And Services Sold $1.6M
Operating Income -$22M
Selling General And Administrative $36M
Research And Development $63M
Operating Expenses $102M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.6M
Income Before Tax -$9.7M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$9.7M
Comprehensive Income Net Of Tax -
Ebit -$20M
Ebitda -$18M
Net Income -$9.7M

FULC News

FULC Profile

Fulcrum Therapeutics Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Fulcrum Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in Cambridge, Massachusetts, dedicated to advancing therapies for genetically defined diseases with significant unmet medical needs. With a robust pipeline centered on addressing conditions such as Duchenne Muscular Dystrophy, Fulcrum aims to transform patient care through innovative drug development. The company's commitment to leveraging its proprietary drug discovery platform underscores its strategic focus on precision medicine and its potential to deliver meaningful clinical benefits.

ATCH
+84.47%
$1.59
NVDA
-2.62%
$170.29
PLUG
+19.04%
$2.00
CGBS
-39.47%
$0.03
CDT
+40.10%
$0.89
BITF
+5.53%
$3.05
SNAP
+3.16%
$7.98
NFE
+8.00%
$2.16
SPRC
+142.93%
$4.47
NIO
+6.05%
$7.44
QBTS
+19.44%
$22.66
GRAB
-3.48%
$6.10
TSLA
+1.00%
$425.86
AAL
+0.84%
$12.51
LYFT
+13.12%
$22.84
GV
+68.16%
$2.80
NUAI
-4.00%
$0.45
MARA
-1.08%
$17.34
SOUN
+3.25%
$15.16
KDLY
+20.96%
$1.50
SOFI
-1.02%
$27.14
RGTI
+9.92%
$21.98
TPIC
-45.91%
$0.12
DNN
+1.40%
$2.53
AXDX
-61.36%
$0.03
ADAP
-1.22%
$0.08
BBD
+2.95%
$3.30
PLTR
-1.11%
$168.36
PGRE
-11.43%
$6.54
F
+0.52%
$11.67
INTC
-1.46%
$24.90
BMNR
+1.98%
$57.04
TNMG
-0.27%
$0.32
IPM
+29.01%
$2.49
LYT
-16.77%
$0.09
JOBY
-1.59%
$14.16
BTG
+0.46%
$4.34
MULN
-12.58%
$0.06
WBD
-1.42%
$17.98
RR
+2.84%
$3.98
NAKA
-4.66%
$1.43
RIVN
-1.46%
$14.11
AAPL
+0.35%
$238.99
UBER
-4.95%
$92.98
ACHR
-0.98%
$9.02
ONDS
+0.16%
$6.10
QS
+1.08%
$10.26
IONQ
+4.97%
$65.36
ABEV
0.00%
$2.36
AIRE
-1.57%
$1.25
LDI
+2.70%
$4.55
PFE
+0.56%
$24.03
RIOT
+0.82%
$17.66
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
WULF
+3.93%
$11.37
OPI
-31.80%
$0.56
RELI
+6.58%
$0.72
TLRY
-2.45%
$1.19
AMD
-0.60%
$159.49
ETHD
-1.52%
$3.22
SRM
+53.27%
$10.30
VALE
-0.27%
$10.88
BINI
-10.60%
$0.05
NOK
+1.84%
$4.69
GOOGL
-0.64%
$249.53
CIFR
+7.55%
$12.38
IREN
+3.97%
$37.90
NWTN
+12.58%
$1.70
CWD
+19.05%
$7.56
AMZN
-1.40%
$230.76
JD
+1.52%
$35.24
ATYR
-5.09%
$1.02
QUBT
+5.21%
$17.75
ITUB
+1.82%
$7.27
INFY
+3.60%
$17.67
RZLV
-3.60%
$7.08
RIG
-1.87%
$3.40
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
KEY
+0.45%
$18.71
DVLT
-21.32%
$0.35
FAAS
-8.85%
$0.08
BABA
+2.39%
$166.09
HOOD
+1.23%
$118.82
BAC
+1.41%
$51.37
BTE
-2.49%
$2.54
WLGS
-5.57%
$0.04
T
-0.97%
$29.33
HBAN
+0.63%
$17.54
CLSK
+2.14%
$11.44
JBLU
0.00%
$5.07
BURU
-0.93%
$0.13
HIMS
-1.08%
$50.34
ETWO
0.00%
$3.30
CAN
+0.23%
$0.80
PEB
+2.03%
$11.79
RAYA
-3.83%
$0.04
GDXD
+2.45%
$1.25
IONZ
-10.28%
$4.80
ATCH
+84.47%
$1.59
NVDA
-2.62%
$170.29
PLUG
+19.04%
$2.00
CGBS
-39.47%
$0.03
CDT
+40.10%
$0.89
BITF
+5.53%
$3.05
SNAP
+3.16%
$7.98
NFE
+8.00%
$2.16
SPRC
+142.93%
$4.47
NIO
+6.05%
$7.44
QBTS
+19.44%
$22.66
GRAB
-3.48%
$6.10
TSLA
+1.00%
$425.86
AAL
+0.84%
$12.51
LYFT
+13.12%
$22.84
GV
+68.16%
$2.80
NUAI
-4.00%
$0.45
MARA
-1.08%
$17.34
SOUN
+3.25%
$15.16
KDLY
+20.96%
$1.50
SOFI
-1.02%
$27.14
RGTI
+9.92%
$21.98
TPIC
-45.91%
$0.12
DNN
+1.40%
$2.53
AXDX
-61.36%
$0.03
ADAP
-1.22%
$0.08
BBD
+2.95%
$3.30
PLTR
-1.11%
$168.36
PGRE
-11.43%
$6.54
F
+0.52%
$11.67
INTC
-1.46%
$24.90
BMNR
+1.98%
$57.04
TNMG
-0.27%
$0.32
IPM
+29.01%
$2.49
LYT
-16.77%
$0.09
JOBY
-1.59%
$14.16
BTG
+0.46%
$4.34
MULN
-12.58%
$0.06
WBD
-1.42%
$17.98
RR
+2.84%
$3.98
NAKA
-4.66%
$1.43
RIVN
-1.46%
$14.11
AAPL
+0.35%
$238.99
UBER
-4.95%
$92.98
ACHR
-0.98%
$9.02
ONDS
+0.16%
$6.10
QS
+1.08%
$10.26
IONQ
+4.97%
$65.36
ABEV
0.00%
$2.36
AIRE
-1.57%
$1.25
LDI
+2.70%
$4.55
PFE
+0.56%
$24.03
RIOT
+0.82%
$17.66
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
WULF
+3.93%
$11.37
OPI
-31.80%
$0.56
RELI
+6.58%
$0.72
TLRY
-2.45%
$1.19
AMD
-0.60%
$159.49
ETHD
-1.52%
$3.22
SRM
+53.27%
$10.30
VALE
-0.27%
$10.88
BINI
-10.60%
$0.05
NOK
+1.84%
$4.69
GOOGL
-0.64%
$249.53
CIFR
+7.55%
$12.38
IREN
+3.97%
$37.90
NWTN
+12.58%
$1.70
CWD
+19.05%
$7.56
AMZN
-1.40%
$230.76
JD
+1.52%
$35.24
ATYR
-5.09%
$1.02
QUBT
+5.21%
$17.75
ITUB
+1.82%
$7.27
INFY
+3.60%
$17.67
RZLV
-3.60%
$7.08
RIG
-1.87%
$3.40
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
KEY
+0.45%
$18.71
DVLT
-21.32%
$0.35
FAAS
-8.85%
$0.08
BABA
+2.39%
$166.09
HOOD
+1.23%
$118.82
BAC
+1.41%
$51.37
BTE
-2.49%
$2.54
WLGS
-5.57%
$0.04
T
-0.97%
$29.33
HBAN
+0.63%
$17.54
CLSK
+2.14%
$11.44
JBLU
0.00%
$5.07
BURU
-0.93%
$0.13
HIMS
-1.08%
$50.34
ETWO
0.00%
$3.30
CAN
+0.23%
$0.80
PEB
+2.03%
$11.79
RAYA
-3.83%
$0.04
GDXD
+2.45%
$1.25
IONZ
-10.28%
$4.80
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.